1. Mizuta, E, Kokubo, Y, Yamanaka, I et al. (2008) Leptin gene and leptin receptor gene polymorphisms are associated with sweet preference and obesity. Hypertens Res 31, 1069–1077.
2. Wardle, J, Carnell, S, Haworth, CM et al. (2008) Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 93, 3640–3643.
3. Combarros, O, Cortina-Borja, M, Smith, AD et al. (2008) Epistasis in sporadic Alzheimer's disease. Neurobiol Aging (Epublication ahead of print version).
4. Isaacs, A, Aulchenko, YS, Hofman, A et al. (2007) Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels. J Clin Endocrinol Metab 92, 2680–2687.
5. Ordovas, JM (2007) Gender, a significant factor in the cross talk between genes, environment, and health. Gend Med 4, Suppl. B, S111–S122.
6. Wang, K (2008) Genetic association tests in the presence of epistasis or gene-environment interaction. Genet Epidemiol 32, 606–614.
7. Botstein, D & Risch, N (2003) Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33, Suppl., 228–237.
8. Gusella, JF (1984) Genetic linkage of the Huntington's disease gene to a DNA marker. Can J Neurol Sci 11, 421–425.
9. Riordan, JR, Rommens, JM, Kerem, B et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073.
10. Strachan, T & Read, AP (2004) Mapping and Identifying Genes Conferring Susceptibility to Complex Diseases. London and New York: Garland Science.
11. Arnett, DK, Baird, AE, Barkley, RA et al. (2007) Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115, 2878–2901.
12. Chiodini, BD & Lewis, CM (2003) Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler Thromb Vasc Biol 23, 1863–1868.
13. Helgadottir, A, Manolescu, A, Thorleifsson, G et al. (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36, 233–239.
14. Pearson, TA & Manolio, TA (2008) How to interpret a genome-wide association study. JAMA 299, 1335–1344.
15. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678.
16. Forabosco, P, Bouzigon, E, Ng, MY et al. (2008) Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet (Epublication ahead of print version).
17. Loos, RJ & Bouchard, C (2008) FTO: the first gene contributing to common forms of human obesity. Obes Rev 3, 246–250.
18. Ozaki, K & Tanaka, T (2005) Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol Life Sci 62, 1804–1813.
19. Samani, NJ, Erdmann, J, Hall, AS et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357, 443–453.
20. Willer, CJ, Sanna, S, Jackson, AU et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40, 161–169.
21. Zeggini, E, Scott, LJ, Saxena, R et al. (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40, 638–645.
22. Humphries, SE, Cooper, JA, Talmud, PJ et al. (2007) Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy UK men. Clin Chem 53, 8–16.
23. Keavney, B, Palmer, A, Parish, S et al. (2004) Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol 33, 1002–1013.
24. Knoblauch, H, Bauerfeind, A, Toliat, MR et al. (2004) Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet 13, 993–1004.
25. Lusis, AJ, Fogelman, AM & Fonarow, GC (2004) Genetic basis of atherosclerosis: part II: clinical implications. Circulation 110, 2066–2071.
26. Lusis, AJ, Fogelman, AM & Fonarow, GC (2004) Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation 110, 1868–1873.
27. McCarthy, JJ, Parker, A, Salem, R et al. (2004) Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 41, 334–341.
28. Olano-Martin, E, Abraham, EC, Gill-Garrison, R et al. (2008) Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender. J Lipid Res 49, 945–953.
29. Masson, LF, McNeill, G & Avenell, A (2003) Genetic variation and the lipid response to dietary intervention: a systematic review. Am J Clin Nutr 77, 1098–1111.
30. Minihane, AM, Jofre-Monseny, L, Olano-Martin, E et al. (2007) Apolipoprotein E genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nutr Soc 66, 183–197.
31. Ordovas, JM & Tai, ES (2008) Why study gene-environment interactions? Curr Opin Lipidol 19, 158–167.
32. Stephens, JW, Bain, SC & Humphries, SE (2008) Gene-environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis 200, 229–238.
33. Hirschhorn, JN, Lohmueller, K, Byrne, E et al. (2002) A comprehensive review of genetic association studies. Genet Med 4, 45–61.
34. Ioannidis, JP, Ntzani, EE, Trikalinos, TA et al. (2001) Replication validity of genetic association studies. Nat Genet 29, 306–309.
35. NCI-NHGRI Working Group on Replication in Association Studies, Chanock, SJ, Manolio, T et al. (2007) Replicating genotype-phenotype associations. Nature 447, 655–660.
36. Shore, VG & Shore, B (1973) Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components. Biochemistry 12, 502–507.
37. Dietrich, M, Hu, Y, Block, G et al. (2005) Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Lipids 40, 329–334.
38. Jofre-Monseny, L, Loboda, A, Wagner, AE et al. (2007) Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Commun 357, 319–324.
39. Jofre-Monseny, L, Minihane, AM & Rimbach, G (2008) Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 52, 131–145.
40. Vitek, MP, Brown, CM & Colton, CA (2007) APOE genotype-specific differences in the innate immune response. Neurobiol Aging (Epublication ahead of print version).
41. Eichner, JE, Dunn, ST, Perveen, G et al. (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155, 487–495.
42. Singh, P, Singh, M & Mastana, S (2006) APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 33, 297–308.
44. Lao, O, Dupanloup, I, Barbujani, G et al. (2008) The Mediterranean paradox for susceptibility factors in coronary heart disease extends to genetics. Ann Hum Genet 72, 48–56.
45. Bennet, AM, Di Angelantonio, E, Ye, Z et al. (2007) Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298, 1300–1311.
46. Song, Y, Stampfer, MJ & Liu, S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141, 137–147.
47. Wilson, PW, Schaefer, EJ, Larson, MG et al. (1996) Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 16, 1250–1255.
48. Elosua, R, Ordovas, JM, Cupples, LA et al. (2004) Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J Lipid Res 45, 1868–1875.
49. Lahoz, C, Schaefer, EJ, Cupples, LA et al. (2001) Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154, 529–537.
50. Wilson, PW, Myers, RH, Larson, MG et al. (2001) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272, 1666–1671.
51. Banares, VG, Peterson, G, Aguilar, D et al. (2005) Association between the APOE*4 allele and atherosclerosis is age dependent among Argentine males. Hum Biol 77, 247–256.
52. Ilveskoski, E, Perola, M, Lehtimaki, T et al. (1999) Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. Circulation 100, 608–613.
53. Jarvik, GP, Austin, MA, Fabsitz, RR et al. (1994) Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genet Epidemiol 11, 375–384.
54. Kolovou, GD & Anagnostopoulou, KK (2007) Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev 6, 94–108.
55. Kuusisto, J, Mykkanen, L, Kervinen, K et al. (1995) Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 15, 1280–1286.
56. Zdravkovic, S, Wienke, A, Pedersen, NL et al. (2002) Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 252, 247–254.
57. Pardo Silva, MC, Janssens, AC, Hofman, A et al. (2008) Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study. Eur J Epidemiol 23, 135–142.
58. Corella, D, Guillen, M, Saiz, C et al. (2001) Environmental factors modulate the effect of the APOE genetic polymorphism on plasma lipid concentrations: ecogenetic studies in a Mediterranean Spanish population. Metabolism 50, 936–944.
59. Etnier, JL, Caselli, RJ, Reiman, EM et al. (2007) Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness. Med Sci Sports Exerc 39, 199–207.
60. Corella, D, Tucker, K, Lahoz, C et al. (2001) Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 73, 736–745.
61. Djousse, L, Pankow, JS, Arnett, DK et al. (2004) Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 80, 1639–1644.
62. Humphries, S, Talmud, P, Hawe, E et al. (2001) Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 358, 115–119.
63. Yang, Y, Ruiz-Narvaez, E, Kraft, P et al. (2007) Effect of apolipoprotein E genotype and saturated fat intake on plasma lipids and myocardial infarction in the Central Valley of Costa Rica. Hum Biol 79, 637–647.
64. Loktionov, A, Scollen, S, McKeown, N et al. (2000) Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals. Br J Nutr 84, 885–890.
65. Wu, K, Bowman, R, Welch, AA et al. (2007) Apolipoprotein E polymorphisms, dietary fat and fibre, and serum lipids: the EPIC Norfolk study. Eur Heart J 28, 2930–2036.
66. Sarkkinen, E, Korhonen, M, Erkkila, A et al. (1998) Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am J Clin Nutr 68, 1215–1222.
67. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354, 447–455.
68. Kris-Etherton, PM, Harris, WS & Appel, LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
69. Balk, EM, Lichtenstein, AH, Chung, M et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189, 19–30.
70. Harris, WS (1997) n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, Suppl., 1645S–1654S.
71. Leigh-Firbank, EC, Minihane, AM, Leake, DS et al. (2002) Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Br J Nutr 87, 435–445.
72. Minihane, AM, Khan, S, Leigh-Firbank, EC et al. (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20, 1990–1997.
73. Caslake, MJ, Miles, EA, Kofler, BM et al. (2008) Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 88, 618–629.
74. Kris-Etherton, PM, Harris, WS & Appel, LJ (2002) AHA Scientific Statement. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
75. Brasaemle, DL, Rubin, B, Harten, IA et al. (2000) Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 275, 38486–38493.
76. Tai, ES & Ordovas, JM (2007) The role of perilipin in human obesity and insulin resistance. Curr Opin Lipidol 18, 152–156.
77. Wang, S, Soni, KG, Semache, M et al. (2008) Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab 95, 117–126.
78. Tansey, JT, Sztalryd, C, Gruia-Gray, J et al. (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 98, 6494–6499.
79. Kern, PA, Di Gregorio, G, Lu, T et al. (2004) Perilipin expression in human adipose tissue is elevated with obesity. J Clin Endocrinol Metab 89, 1352–1358.
80. Qi, L, Corella, D, Sorli, JV et al. (2004) Genetic variation at the perilipin (PLIN) locus is associated with obesity-related phenotypes in White women. Clin Genet 66, 299–310.
81. Qi, L, Shen, H, Larson, I et al. (2004) Gender-specific association of a perilipin gene haplotype with obesity risk in a white population. Obes Res 12, 1758–1765.
82. Perez-Martinez, P, Yiannakouris, N, Lopez-Miranda, J et al. (2008) Postprandial triacylglycerol metabolism is modified by the presence of genetic variation at the perilipin (PLIN) locus in 2 white populations. Am J Clin Nutr 87, 744–752.
83. Corella, D, Qi, L, Sorli, JV et al. (2005) Obese subjects carrying the 11482G>A polymorphism at the perilipin locus are resistant to weight loss after dietary energy restriction. J Clin Endocrinol Metab 90, 5121–5126.
84. Kang, ES, Cha, BS, Kim, HJ et al. (2006) The 11482G>A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes. Diabetes Care 29, 1320–1324.
85. Corella, D, Qi, L, Tai, ES et al. (2006) Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes Care 29, 1313–1319.
86. Bansal, S, Buring, JE, Rifai, N et al. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298, 309–316.
87. Eberly, LE, Stamler, J & Neaton, JD (2003) Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med 163, 1077–1083.
88. Nordestgaard, BG, Benn, M, Schnohr, P et al. (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299–308.
89. Stensvold, I, Tverdal, A, Urdal, P et al. (1993) Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. Br Med J 307, 1318–1322.
90. Benlian, P, De Gennes, JL, Foubert, L et al. (1996) Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 335, 848–854.
91. Perez-Martinez, P, Lopez-Miranda, J, Perez-Jimenez, F et al. (2008) Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler Suppl 9, 49–55.
92. Pennacchio, LA, Olivier, M, Hubacek, JA et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169–173.
93. Wong, K & Ryan, RO (2007) Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation. Curr Opin Lipidol 18, 319–324.
94. Elosua, R, Ordovas, JM, Cupples, LA et al. (2006) Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res 47, 990–996.
95. Tai, ES & Ordovas, JM (2008) Clinical significance of apolipoprotein A5. Curr Opin Lipidol 19, 349–354.
96. Talmud, PJ, Martin, S, Taskinen, MR et al. (2004) APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 45, 750–756.
97. Jang, Y, Kim, JY, Kim, OY et al. (2004) The −1131T33→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr 80, 832–840.
98. Kim, JY, Kim, OY, Koh, SJ et al. (2006) Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the –1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design). J Am Coll Nutr 25, 340–347.
99. Martin, S, Nicaud, V, Humphries, SE et al. (2003) Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637, 217–225.
100. Moreno, R, Perez-Jimenez, F, Marin, C et al. (2006) A single nucleotide polymorphism of the apolipoprotein A-V gene –1131T>C modulates postprandial lipoprotein metabolism. Atherosclerosis 189, 163–168.
101. Moreno-Luna, R, Perez-Jimenez, F, Marin, C et al. (2007) Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population. J Clin Endocrinol Metab 92, 2280–2285.
102. Lai, CQ, Corella, D, Demissie, S et al. (2006) Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation 113, 2062–2070.
103. Drenos, F, Whittaker, JC & Humphries, SE (2007) The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. Ann Hum Genet 71, 611–619.
104. Yang, Q, Khoury, MJ, Friedman, J et al. (2005) How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol 34, 1129–1137.
105. Mardis, ER (2006) Anticipating the 1,000 dollar genome. Genome Biol 7, 112.